Respiratory Virus Vaccines Market
Respiratory Virus Vaccines Market Analysis by Inactivated/Killed, Live-attenuated, and Recombinant for Influenza, Measles, Mumps, & Rubella, and Coronavirus Disease (COVID-19) from 2023 to 2033
Analysis of Respiratory Virus Vaccines Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
- FACT5199MR
- 12 Jul 2023
- Healthcare
- 170 Pages
- 43 Tables
- 95 Figures
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Risks & Trends Assessment
- 4. Market Background and Associated Industry Indicators
- 5. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033
- 6. Global Market - Pricing Analysis
- 7. Global Market Demand (in US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033
- 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
- 8.1. Inactivated/Killed Vaccines
- 8.2. Live-attenuated Vaccines
- 8.3. Recombinant Vaccines
- 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Route of Administration
- 9.1. Intramuscular
- 9.2. Intranasal
- 9.3. Subcutaneous
- 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
- 10.1. Influenza
- 10.2. Measles, Mumps & Rubella
- 10.3. Coronavirus Disease (COVID-19)
- 11. Global Market Value (US$ Mn) Forecast, by Age Group
- 11.1. Pediatric
- 11.2. Adults
- 12. Global Market Attractiveness Analysis, by Age Group
- 13. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
- 13.1. Physician’s Office
- 13.2. Hospitals
- 13.3. Clinics
- 13.4. Pharmacies/Stores
- 14. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
- 14.1. North America
- 14.2. Latin America
- 14.3. Europe
- 14.4. Asia Pacific
- 14.5. Middle East & Africa
- 15. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 16. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 17. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 18. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 19. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 20. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 21. Market Structure Analysis
- 22. Competition Analysis
- 22.1. CSL Limited
- 22.2. Sanofi
- 22.3. AstraZeneca
- 22.4. Merck & Co., Inc.
- 22.5. GlaxoSmithKline plc
- 22.6. Serum Institute of India Pvt. Ltd.
- 22.7. Bharat Biotech
- 22.8. Sinovac Biotech Ltd.
- 23. Assumptions and Acronyms Used
- 24. Research Methodology
List Of Table
Table 01: Pipeline Analysis (1/4)
Table 02: Pipeline Analysis (2/4)
Table 03: Pipeline Analysis (3/4)
Table 04: Pipeline Analysis (4/4)
Table 05: Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.) (1/3)
Table 06: Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.) (2/3)
Table 07: Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.) (3/3)
Table 08: Global Market Value (US$ Mn) Forecast, by Type, 2023 to 2033
Table 09: Global Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033
Table 10: Global Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 11: Global Market Value (US$ Mn) Forecast, by Age Group, 2023 to 2033
Table 12: Global Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033
Table 13: Global Market Value (US$ Mn) Forecast, by Region, 2023 to 2033
Table 14: North America Market Value (US$ Mn) Forecast, by Country, 2023 to 2033
Table 15: North America Market Value (US$ Mn) Forecast, by Type, 2023 to 2033
Table 16: North America Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033
Table 17: North America Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 18: North America Market Value (US$ Mn) Forecast, by Age Group, 2023 to 2033
Table 19: North America Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033
Table 20: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 21: Europe Market Value (US$ Mn) Forecast, by Type, 2023 to 2033
Table 22: Europe Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033
Table 23: Europe Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 24: Europe Market Value (US$ Mn) Forecast, by Age Group, 2023 to 2033
Table 25: Europe Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033
Table 26: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 27: Asia Pacific Market Value (US$ Mn) Forecast, by Type, 2023 to 2033
Table 28: Asia Pacific Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033
Table 29: Asia Pacific Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 30: Asia Pacific Market Value (US$ Mn) Forecast, by Age Group, 2023 to 2033
Table 31: Asia Pacific Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033
Table 32: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 33: Latin America Market Value (US$ Mn) Forecast, by Type, 2023 to 2033
Table 34: Latin America Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033
Table 35: Latin America Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 36: Latin America Market Value (US$ Mn) Forecast, by Age Group, 2023 to 2033
Table 37: Latin America Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033
Table 38: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 39: Middle East & Africa Market Value (US$ Mn) Forecast, by Type, 2023 to 2033
Table 40: Middle East & Africa Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033
Table 41: Middle East & Africa Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 42: Middle East & Africa Market Value (US$ Mn) Forecast, by Age Group, 2023 to 2033
Table 43: Middle East & Africa Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033
List Of Figures
Figure 01: Global Market Value (US$ Mn) Forecast, 2023 to 2033
Figure 02: Global Market Value Share Analysis, by Type, 2018 and 2022
Figure 03: Global Market Attractiveness Analysis, by Type, 2018 to 2022
Figure 04: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Inactivated/Killed Vaccines, 2023 to 2033
Figure 05: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Live-attenuated Vaccines, 2023 to 2033
Figure 06: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Recombinant vaccines, 2023 to 2033
Figure 07: Global Market Value Share Analysis, by Route of Administration, 2018 and 2022
Figure 08: Global Market Attractiveness Analysis, by Route of Administration, 2018 to 2022
Figure 09: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Intramuscular, 2023 to 2033
Figure 10: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Intranasal, 2023 to 2033
Figure 11: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Subcutaneous, 2023 to 2033
Figure 12: Global Market Value Share Analysis, by Indication, 2018 and 2022
Figure 13: Global Market Attractiveness Analysis, by Indication, 2018 to 2022
Figure 14: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Influenza, 2023 to 2033
Figure 15: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Measles, Mumps & Rubella, 2023 to 2033
Figure 16: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Coronavirus Disease (COVID-19), 2023 to 2033
Figure 17: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2023 to 2033
Figure 18: Global Market Value Share Analysis, by Age Group, 2018 and 2022
Figure 19: Global Market Attractiveness Analysis, by Age Group, 2018 to 2022
Figure 20: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Pediatric, 2023 to 2033
Figure 21: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Adult, 2023 to 2033
Figure 22: Global Market Value Share Analysis, by End-user, 2018 and 2022
Figure 23: Global Market Attractiveness Analysis, by End-user, 2018 to 2022
Figure 24: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Physician Offices, 2023 to 2033
Figure 25: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2023 to 2033
Figure 26: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Clinics, 2023 to 2033
Figure 27: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Pharmacy/Store, 2023 to 2033
Figure 28: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2023 to 2033
Figure 29: Global Market Value Share Analysis, by Region, 2018 and 2022
Figure 30: Global Market Attractiveness Analysis, by Region, 2018 to 2022
Figure 31: North America Market Value (US$ Mn) Forecast, 2023 to 2033
Figure 32: North America Market Value Share Analysis, by Country, 2018 and 2022
Figure 33: North America Market Attractiveness Analysis, by Country, 2018 to 2022
Figure 34: North America Market Value Share Analysis, by Type, 2018 and 2022
Figure 35: North America Market Attractiveness Analysis, by Type, 2018 to 2022
Figure 36: North America Market Value Share Analysis, by Route of Administration, 2018 and 2022
Figure 37: North America Market Attractiveness Analysis, by Route of Administration, 2018 to 2022
Figure 38: North America Market Value Share Analysis, by Indication, 2018 and 2022
Figure 39: North America Market Attractiveness Analysis, by Indication, 2018 to 2022
Figure 40: North America Market Value Share Analysis, by Age Group, 2018 and 2022
Figure 41: North America Market Attractiveness Analysis, by Age Group, 2018 to 2022
Figure 42: North America Market Value Share Analysis, by End-user, 2018 and 2022
Figure 43: North America Market Attractiveness Analysis, by End-user, 2018 to 2022
Figure 44: Europe Market Value (US$ Mn) Forecast, 2023 to 2033
Figure 45: Europe Market Value Share Analysis, by Country/Sub-region, 2018 and 2022
Figure 46: Europe Market Attractiveness Analysis, by Country, 2018 to 2022
Figure 47: Europe Market Value Share Analysis, by Type, 2018 and 2022
Figure 48: Europe Market Attractiveness Analysis, by Type, 2018 to 2022
Figure 49: Europe Market Value Share Analysis, by Route of Administration, 2018 and 2022
Figure 50: Europe Market Attractiveness Analysis, by Route of Administration, 2018 to 2022
Figure 51: Europe Market Value Share Analysis, by Indication, 2018 and 2022
Figure 52: Europe Market Attractiveness Analysis, by Indication, 2018 to 2022
Figure 53: Europe Market Value Share Analysis, by Age Group, 2018 and 2022
Figure 54: Europe Market Attractiveness Analysis, by Age Group, 2018 to 2022
Figure 55: Europe Market Value Share Analysis, by End-user, 2018 and 2022
Figure 56: Europe Market Attractiveness Analysis, by End-user, 2018 to 2022
Figure 57: Asia Pacific Market Value (US$ Mn) Forecast, 2023 to 2033
Figure 58: Asia Pacific Market Value Share Analysis, by Country/Sub-region, 2018 and 2022
Figure 59: Asia Pacific Market Attractiveness Analysis, by Country/Sub-region, 2018 to 2022
Figure 60: Asia Pacific Market Value Share Analysis, by Type, 2018 and 2022
Figure 61: Asia Pacific Market Attractiveness Analysis, by Type, 2018 to 2022
Figure 62: Asia Pacific Market Value Share Analysis, by Route of Administration, 2018 and 2022
Figure 63: Asia Pacific Market Attractiveness Analysis, by Route of Administration, 2018 to 2022
Figure 64: Asia Pacific Market Value Share Analysis, by Indication, 2018 and 2022
Figure 65: Asia Pacific Market Attractiveness Analysis, by Indication, 2018 to 2022
Figure 66: Asia Pacific Market Value Share Analysis, by Age Group, 2018 and 2022
Figure 67: Asia Pacific Market Attractiveness Analysis, by Age Group, 2018 to 2022
Figure 68: Asia Pacific Market Value Share Analysis, by End-user, 2018 and 2022
Figure 69: Asia Pacific Market Attractiveness Analysis, by End-user, 2018 to 2022
Figure 70: Latin America Market Value (US$ Mn) Forecast, 2023 to 2033
Figure 71: Latin America Market Value Share Analysis, by Country/Sub-region, 2018 and 2022
Figure 72: Latin America Market Attractiveness Analysis, by Country/Sub-region, 2018 to 2022
Figure 73: Latin America Market Value Share Analysis, by Type, 2018 and 2022
Figure 74: Latin America Market Attractiveness Analysis, by Type, 2018 to 2022
Figure 75: Latin America Market Value Share Analysis, by Route of Administration, 2018 and 2022
Figure 76: Latin America Market Attractiveness Analysis, by Route of Administration, 2018 to 2022
Figure 77: Latin America Market Value Share Analysis, by Indication, 2018 and 2022
Figure 78: Latin America Market Attractiveness Analysis, by Indication, 2018 to 2022
Figure 79: Latin America Market Value Share Analysis, by Age Group, 2018 and 2022
Figure 80: Latin America Market Attractiveness Analysis, by Age Group, 2018 to 2022
Figure 81: Latin America Market Value Share Analysis, by End-user, 2018 and 2022
Figure 82: Latin America Market Attractiveness Analysis, by End-user, 2018 to 2022
Figure 83: Middle East & Africa Market Value (US$ Mn) Forecast, 2023 to 2033
Figure 84: Middle East & Africa Market Value Share Analysis, by Country/Sub-region, 2018 and 2022
Figure 85: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region, 2018 to 2022
Figure 86: Middle East & Africa Market Value Share Analysis, by Type, 2018 and 2022
Figure 87: Middle East & Africa Market Attractiveness Analysis, by Type, 2018 to 2022
Figure 88: Middle East & Africa Market Value Share Analysis, by Route of Administration, 2018 and 2022
Figure 89: Middle East & Africa Market Attractiveness Analysis, by Route of Administration, 2018 to 2022
Figure 90: Middle East & Africa Market Value Share Analysis, by Indication, 2018 and 2022
Figure 91: Middle East & Africa Market Attractiveness Analysis, by Indication, 2018 to 2022
Figure 92: Middle East & Africa Market Value Share Analysis, by Age Group, 2018 and 2022
Figure 93: Middle East & Africa Market Attractiveness Analysis, by Age Group, 2018 to 2022
Figure 94: Middle East & Africa Market Value Share Analysis, by End-user, 2018 and 2022
Figure 95: Middle East & Africa Market Attractiveness Analysis, by End-user, 2018 to 2022
Respiratory Virus Vaccines Market